HEMO

HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01

TitleTime
Exercise of WarrantsMon 18/05/20 | 10:56
Posting of Annual Report & Notice of AGMWed 13/05/20 | 09:42
Second Price Monitoring ExtnTue 12/05/20 | 16:41
Price Monitoring ExtensionTue 12/05/20 | 16:36
Conditional Placing to raise £2,500,000Tue 12/05/20 | 14:22
Second Price Monitoring ExtnMon 11/05/20 | 14:06
Price Monitoring ExtensionMon 11/05/20 | 14:00
Second Price Monitoring ExtnMon 11/05/20 | 09:05
Price Monitoring ExtensionMon 11/05/20 | 09:00
Second Price Monitoring ExtnThu 07/05/20 | 16:41
Price Monitoring ExtensionThu 07/05/20 | 16:36
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESThu 07/05/20 | 13:59
Second Price Monitoring ExtnTue 05/05/20 | 16:41
Price Monitoring ExtensionTue 05/05/20 | 16:36
Second Price Monitoring ExtnTue 05/05/20 | 14:06
Price Monitoring ExtensionTue 05/05/20 | 14:00
Second Price Monitoring ExtnTue 05/05/20 | 11:06
Price Monitoring ExtensionTue 05/05/20 | 11:00
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESMon 04/05/20 | 07:00
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESMon 04/05/20 | 07:00
Second Price Monitoring ExtnFri 01/05/20 | 16:41
Price Monitoring ExtensionFri 01/05/20 | 16:36
Second Price Monitoring ExtnFri 01/05/20 | 14:06
Price Monitoring ExtensionFri 01/05/20 | 14:00
Final ResultsThu 30/04/20 | 16:57
Second Price Monitoring ExtnThu 30/04/20 | 16:40
Price Monitoring ExtensionThu 30/04/20 | 16:36
Second Price Monitoring ExtnThu 30/04/20 | 14:05
Price Monitoring ExtensionThu 30/04/20 | 14:00
Second Price Monitoring ExtnThu 30/04/20 | 11:05
Price Monitoring ExtensionThu 30/04/20 | 11:00
Second Price Monitoring ExtnWed 29/04/20 | 16:42
Price Monitoring ExtensionWed 29/04/20 | 16:36
Second Price Monitoring ExtnWed 29/04/20 | 11:05
Price Monitoring ExtensionWed 29/04/20 | 11:00
Second Price Monitoring ExtnWed 29/04/20 | 09:06
Price Monitoring ExtensionWed 29/04/20 | 09:00
Second Price Monitoring ExtnTue 28/04/20 | 14:06
Price Monitoring ExtensionTue 28/04/20 | 14:00
Second Price Monitoring ExtnTue 28/04/20 | 11:06
Price Monitoring ExtensionTue 28/04/20 | 11:00
Second Price Monitoring ExtnMon 27/04/20 | 16:41
Price Monitoring ExtensionMon 27/04/20 | 16:36
Second Price Monitoring ExtnMon 27/04/20 | 14:06
Price Monitoring ExtensionMon 27/04/20 | 14:00
Second Price Monitoring ExtnWed 22/04/20 | 16:40
Price Monitoring ExtensionWed 22/04/20 | 16:35
Second Price Monitoring ExtnWed 22/04/20 | 14:05
Price Monitoring ExtensionWed 22/04/20 | 14:00
COVID-19 Project InitiatedWed 22/04/20 | 11:00
Approval and Issuance of European Hu-PHEC PatentTue 21/04/20 | 14:26
Second Price Monitoring ExtnThu 02/04/20 | 14:05
Price Monitoring ExtensionThu 02/04/20 | 14:00
Total Voting RightsFri 28/02/20 | 18:30
HEMO-CAR-T cells Effective Against AML in vivoThu 20/02/20 | 07:00
Approval and Issuance of U.S. Hu-PHEC PatentTue 11/02/20 | 07:00
Director/PDMR ShareholdingFri 31/01/20 | 07:00
Placing and Subscription to raise £650,000Thu 30/01/20 | 14:05
HEMO's CAR-T Cells Effective Against AML in vitroWed 15/01/20 | 12:30
Operational UpdateMon 18/11/19 | 07:00
Presentation at the Investival ShowcaseTue 12/11/19 | 07:00
Research Agreement with Global Pharma CompanyWed 23/10/19 | 07:00
Half-year ReportMon 30/09/19 | 07:00
Total Voting RightsThu 01/08/19 | 07:00
CDX Patent ApplicationFri 12/07/19 | 07:00
Director/PDMR ShareholdingWed 03/07/19 | 07:00
Result of AGMFri 28/06/19 | 12:19
Development of ApbHCMon 24/06/19 | 07:00
CDX Effective as Conditioning Therapeutic in vivoWed 12/06/19 | 07:00
CDX Antibody is Effective against AML in vivoWed 05/06/19 | 08:15
Second Price Monitoring ExtnThu 30/05/19 | 16:40
Price Monitoring ExtensionThu 30/05/19 | 16:35
CDX Antibody is Effective against ALL in vitroThu 30/05/19 | 07:00
Posting of Annual Report and Notice of AGMTue 28/05/19 | 07:00
Variation of Terms of Warrant InstrumentWed 15/05/19 | 07:00
Director/PDMR ShareholdingWed 01/05/19 | 07:00
Final Results for the Year Ended 31 December 2018Mon 29/04/19 | 15:10
Presentation at Cancer Immunotherapy ConferenceWed 30/01/19 | 07:00
Operations UpdateMon 07/01/19 | 07:00
Directorate ChangeThu 20/12/18 | 07:00
Directorate Change & AppointmentMon 05/11/18 | 07:00
Orgenesis collaboration for Hu-PHEC developmentMon 22/10/18 | 07:00
Collaboration, License and Investment by OrgenesisFri 19/10/18 | 07:00
Collaboration with Johnson & Johnson InnovationMon 15/10/18 | 07:00
Half-year ReportFri 28/09/18 | 09:30
Change of AdviserFri 28/09/18 | 07:00
Hemogenyx to present at Oxford conferenceMon 03/09/18 | 07:00
Result of AGMWed 27/06/18 | 11:39
Posting of Annual Report & Notice of AGMTue 05/06/18 | 18:05
Final ResultsMon 30/04/18 | 16:23
Director/PDMR ShareholdingWed 11/04/18 | 17:15
Directorate ChangeTue 03/04/18 | 07:00
Second Price Monitoring ExtnWed 14/03/18 | 11:05
Price Monitoring ExtensionWed 14/03/18 | 11:00
Collaboration with major US biotechnology companyTue 13/03/18 | 07:00
Advisory Board AppointmentTue 06/03/18 | 07:00
Second Price Monitoring ExtnTue 27/02/18 | 16:40
Price Monitoring ExtensionTue 27/02/18 | 16:35
Stmnt re Share Price MovementMon 26/02/18 | 14:17
Director/PDMR ShareholdingMon 12/02/18 | 07:00
Director/PDMR ShareholdingWed 07/02/18 | 07:00
Result of AGMThu 07/12/17 | 12:16
AGM StatementThu 07/12/17 | 07:00
University of Oxford CollaborationMon 20/11/17 | 07:00
Directorate ChangeWed 15/11/17 | 07:00
Notice of AGMTue 14/11/17 | 07:00
Second Price Monitoring ExtnMon 13/11/17 | 16:40
Price Monitoring ExtensionMon 13/11/17 | 16:35
Second Price Monitoring ExtnMon 13/11/17 | 14:05
Price Monitoring ExtensionMon 13/11/17 | 14:00
Second Price Monitoring ExtnMon 13/11/17 | 11:05
Price Monitoring ExtensionMon 13/11/17 | 11:00
Second Price Monitoring ExtnMon 13/11/17 | 09:05
Price Monitoring ExtensionMon 13/11/17 | 09:00
Statement re Press CommentMon 13/11/17 | 07:00
LakePharma appointed for lead product developmentMon 30/10/17 | 07:00
Director/PDMR ShareholdingWed 11/10/17 | 07:00
Director/PDMR ShareholdingTue 10/10/17 | 07:00
Cornell University updateThu 05/10/17 | 08:01
Admission & First Day of DealingsThu 05/10/17 | 08:00
Result of General MeetingWed 04/10/17 | 11:16
Investor presentationsTue 26/09/17 | 07:00
Half-year ReportMon 25/09/17 | 07:00
Proposed acquisition and Placing & SubscriptionMon 11/09/17 | 07:00